Anti-Inflammatory Effect of Dexamethasone Controlled Released From Anterior Suprachoroidal Polyurethane Implants on Endotoxin-Induced Uveitis in Rats
Author(s) -
Juliana Barbosa Saliba,
Lorena Carla Vieira,
Gabriella Maria Fernandes-Cunha,
Gisele Rodrigues da Silva,
Sílvia Ligório Fialho,
Armando SilvaCunha,
Elodie Bousquet,
MarieChristine Naud,
Eliane Ayres,
Rodrigo Lambert Oréfice,
M. Tekaya,
Laura Kowalczuk,
Min Zhao,
Francine BéharCohen
Publication year - 2016
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.15-18127
Subject(s) - proinflammatory cytokine , dexamethasone , uveitis , chemokine , cytokine , ciliary body , implant , medicine , pharmacology , inflammation , chemistry , immunology , ophthalmology , surgery
Targeted drug delivery to the ocular tissues remains a challenge. Biodegradable intraocular implants allow prolonged controlled release of drugs directly into the eye. In this study, we evaluated an anterior suprachoroidal polyurethane implant containing dexamethasone polyurethane dispersions (DX-PUD) as a drug delivery system in the rat model of endotoxin-induced uveitis (EIU).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom